Drug diluent and efficacy of methylene blue in septic shock: authors’ reply

被引:0
作者
Miguel Ibarra-Estrada
Eduardo Kattan
Guadalupe Aguirre-Avalos
Glenn Hernández
机构
[1] Universidad de Guadalajara,Unidad de Terapia Intensiva, Hospital Civil Fray Antonio Alcalde
[2] Instituto Jalisciense de Cancerología,Departamento de Medicina Intensiva, Facultad de Medicina
[3] The Latin American Intensive Care Network (LIVEN),undefined
[4] Pontificia Universidad Católica de Chile,undefined
来源
Critical Care | / 27卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 53 条
[1]  
Ibarra-Estrada M(2023)Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial Crit Care 27 110-762
[2]  
Kattan E(2002)The influence of methylene blue infusion on cytokine levels during severe sepsis Anaesth Intensive Care 30 755-1867
[3]  
Aguilera-González P(2001)Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study Crit Care Med 29 1860-464
[4]  
Sandoval-Plascencia L(2021)New trends in the utilization of intravenous fluids Cureus 13 461-118
[5]  
Rico-Jauregui U(1967)The stability of noradrenaline in infusion solutions Acta Pharmacol Toxicol (Copenh) 25 113-264
[6]  
Gómez-Partida CA(2010)Stability of norepinephrine solutions in normal saline and 5% dextrose in water Can J Hosp Pharm 63 1014276-1370
[7]  
Memis D(2022)Methylene blue dosing strategies in critically ill adults with shock-A retrospective cohort study Front Med (Lausanne) 9 259-2277
[8]  
Karamanlioglu B(1995)Methylene blue administration in septic shock: a clinical trial Crit Care Med 23 1363-207
[9]  
Yuksel M(1995)Methylene blue increases myocardial function in septic shock Crit Care Med 23 2271-undefined
[10]  
Gemlik I(2002)Does methylene blue administration to septic shock patients affect vascular permeability and blood volume? Crit Care Med 30 206-undefined